Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest of KIORA PHARMACEUTICALS INC from 31 Dec 2016 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Summary: KIORA PHARMACEUTICALS INC quarterly and annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest in USD history and change rate from 31 Dec 2016 to 30 Sep 2025.
KIORA PHARMACEUTICALS INC Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the quarter ending 30 Sep 2025 was $616,323, a 82% increase year-over-year.
KIORA PHARMACEUTICALS INC Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the twelve months ending 30 Sep 2025 was $7,109,310.
KIORA PHARMACEUTICALS INC annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2024 was $5,659,738.
KIORA PHARMACEUTICALS INC annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2023 was $12,423,577, a 9.3% increase from 2022.
KIORA PHARMACEUTICALS INC annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2022 was $13,696,620, a 1.9% increase from 2021.
Source SEC data: View on sec.gov

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Trailing 12 Months (USD)

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Quarterly (USD)

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Quarterly Change (%)

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Annual (USD)

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Annual Change (%)

KIORA PHARMACEUTICALS INC Quarterly Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$7,109,310	$616,323	+$2,797,003	+82%	01 Jul 2025	30 Sep 2025	10-Q	07 Nov 2025	2025	Q3
Q2 2025	$9,906,313	$2,264,516	-$42,870	-1.9%	01 Apr 2025	30 Jun 2025	10-Q	08 Aug 2025	2025	Q2
Q1 2025	$9,863,443	$2,069,974	-$15,523,181	-115%	01 Jan 2025	31 Mar 2025	10-Q	09 May 2025	2025	Q1
Q4 2024	$5,659,738	$2,158,497			01 Oct 2024	31 Dec 2024	10-K	25 Mar 2025	2024	FY
Q3 2024		$3,413,326			01 Jul 2024	30 Sep 2024	10-Q	07 Nov 2025	2025	Q3
Q2 2024		$2,221,646			01 Apr 2024	30 Jun 2024	10-Q	08 Aug 2025	2025	Q2
Q1 2024		$13,453,207			01 Jan 2024	31 Mar 2024	10-Q	09 May 2025	2025	Q1
Q4 2018	$10,725,378	$2,370,133			01 Oct 2018	31 Dec 2018	10-K	04 Mar 2020	2019	FY
Q3 2018		$3,177,878			01 Jul 2018	30 Sep 2018	10-Q	13 Nov 2018	2018	Q3
Q2 2018		$2,798,318			01 Apr 2018	30 Jun 2018	10-Q	03 Aug 2018	2018	Q2
Q1 2018		$2,379,049			01 Jan 2018	31 Mar 2018	10-Q	11 May 2018	2018	Q1

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2024	$5,659,738	+$18,083,315		01 Jan 2024	31 Dec 2024	10-K	25 Mar 2025	2024	FY
2023	$12,423,577	+$1,273,043	+9.3%	01 Jan 2023	31 Dec 2023	10-K	25 Mar 2025	2024	FY
2022	$13,696,620	+$266,668	+1.9%	01 Jan 2022	31 Dec 2022	10-K	25 Mar 2024	2023	FY
2021	$13,963,288	-$7,113,573	-104%	01 Jan 2021	31 Dec 2021	10-K	23 Mar 2023	2022	FY
2020	$6,849,715	+$151,585	+2.2%	01 Jan 2020	31 Dec 2020	10-K/A	07 Jul 2022	2021	FY
2019	$7,001,300	+$3,724,078	+35%	01 Jan 2019	31 Dec 2019	10-K	25 Mar 2021	2020	FY
2018	$10,725,378	+$3,834,512	+26%	01 Jan 2018	31 Dec 2018	10-K	04 Mar 2020	2019	FY
2017	$14,559,890	-$1,216,453	-9.1%	01 Jan 2017	31 Dec 2017	10-K	01 Mar 2019	2018	FY
2016	$13,343,437			01 Jan 2016	31 Dec 2016	10-K	02 Mar 2018	2017	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.